FDA PRIA Reference Data
Summary
The FDA has published reference data related to the Prescription Drug User Fee Act (PRIA) for May 2024. This notice includes national employment data relevant to PRIA submissions. It serves as an informational update for regulated entities.
What changed
The Food and Drug Administration (FDA) has released PRIA Reference 5, dated May 2024, which includes national employment data. This data is likely intended to support or inform submissions made under the Prescription Drug User Fee Act (PRIA).
This document appears to be an informational notice providing reference data for drug manufacturers and medical device makers. No specific actions are mandated by this notice, and it does not appear to introduce new compliance obligations or deadlines. Regulated entities may find this data useful for their PRIA-related activities.
Archived snapshot
Mar 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.